8-K: Green Thumb Reports Strong 2025, Q1 2026 Revenue Dip Expected

Green Thumb Industries reported record fourth-quarter revenue of $311.1 million and full-year revenue of $1.2 billion for 2025, alongside significant share repurchases, but anticipates a sequential revenue decline in Q1 2026.

Summary

• Fourth-quarter 2025 revenue reached $311.1 million, a 5.7% increase year-over-year.
• Full-year 2025 revenue totaled $1.2 billion, up 3.4% from the prior year.
• GAAP net income for Q4 2025 was $83.2 million ($0.36 per basic share), and for the full year was $114.2 million ($0.49 per basic share), largely driven by fair value adjustments on related party warrants.
• Normalized EBITDA for Q4 2025 was $100.2 million (32.2% of revenue), and for the full year was $348.4 million (29.6% of revenue).
• Cash flow from operations was $90.0 million in Q4 and $294.9 million for the full year 2025.
• The company repurchased approximately 2.0 million Subordinate Voting Shares for $14.1 million in Q4, and 7.7 million shares for $38.9 million for the full year 2025.
• Retail footprint expanded by 12 locations, bringing the total to 113 stores nationwide.
• Cash and cash equivalents stood at $274.3 million as of December 31, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed report. While revenue growth and cash flow are strong, declining margins, negative comparable sales, and a cautious Q1 2026 outlook temper the positive operational achievements and brand leadership.

Positives

• Record fourth-quarter revenue of $311.1 million, a 5.7% increase year-over-year.
• Full-year revenue reached $1.2 billion, growing 3.4% despite ongoing price compression.
• Strong cash position with $274.3 million in cash and cash equivalents at year-end.
• Robust cash flow from operations of $90.0 million in Q4 and $294.9 million for the full year.
• Significant share repurchase program, with approximately 15.5 million Subordinate Voting Shares repurchased for $121.8 million since September 2023.
• Expanded retail footprint by 12 locations in 2025, reaching 113 stores nationwide.
• Successful transition to adult-use cannabis in Minnesota in September 2025, contributing meaningfully to Q4 performance.
• Brands hold nationwide leadership positions according to BDSA data for 2025, with RYTHM as the No. 1 flower brand, Dogwalkers as the No. 1 uninfused pre-roll, and incredibles as the No. 1 chocolate brand.
• Increased existing syndicated credit facility by $50 million, enhancing financial flexibility.
• Strategic separation of hemp and cannabis businesses through the sale of brand intellectual property, positioning RYTHM, Inc. as a federally compliant business and Green Thumb for evolving regulatory frameworks.

Negatives

• Gross profit margin declined in Q4 2025 to 45.4% from 53.7% in the prior year, and for the full year to 48.9% from 52.9% in 2024, primarily due to price compression.
• Selling, general and administrative expenses increased significantly in Q4 2025 to $122.3 million (39.3% of revenue) from $101.0 million (34.3% of revenue) in Q4 2024, and for the full year to $437.2 million (37.2% of revenue) from $376.7 million (33.1% of revenue) in 2024, mainly due to new store openings and compensation costs.
• Comparable sales for Q4 2025 decreased by 1.8% year-over-year on a base of 99 stores, indicating a decline in sales at established locations.
• Consumer Packaged Goods' gross revenue decreased by 1% in Q4 2025 versus the prior year period, primarily due to price compression and increased competition.
• Normalized EBITDA for the full year 2025 decreased to $348.4 million from $371.3 million in 2024.
• Cannabis reform in D.C. continues to stall, creating ongoing regulatory uncertainty.
• Unfavorable fair value adjustments on the company's equity investments contributed to other income (expense) in Q4 2025, excluding the warrant adjustment.

Risks

• Cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change.
• Future state regulation of cannabis is uncertain.
• May not be able to obtain or maintain necessary permits and authorizations.
• May face limitations on ownership of cannabis licenses.
• May become subject to U.S. Food and Drug Administration or the U.S. Bureau of Alcohol, Tobacco, Firearms, and Explosives regulation.
• As a cannabis business, the Company is subject to applicable anti-money laundering laws and regulations and has restricted access to banking and other financial services.
• May face difficulties acquiring additional financing.
• Operates in a highly regulated sector and may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where it conducts business.
• Faces intense competition, including from the illicit market and hemp products.
• Dependent upon the popularity and consumer acceptance of its brand portfolio that the Company licenses from a third party.
• Has limited trademark protections.
• As a cannabis business, the Company is subject to unfavorable tax treatment and may incur significant tax liability.
• As a cannabis business, the Company may be subject to civil asset forfeiture and proceeds of crime statutes.
• Faces exposure to fraudulent or illegal activity.
• Faces risks due to industry immaturity or limited comparable, competitive or established industry best practices.
• Faces risks related to its products, including those inherent in agricultural operations, product liability, and potential product recalls.
• May face unfavorable publicity or consumer perception.
• May be adversely impacted by rising or volatile energy costs and availability.
• Faces risks related to its information technology systems and potential cyber-attacks and security breaches.
• Relies on third-party software providers for numerous capabilities, and a disruption could adversely affect the business.
• Relies on the expertise of its management team and other employees, and the loss of key personnel could negatively affect its business.
• Voting control is concentrated, and the capital structure and voting control may cause unpredictability.
• Sales of substantial amounts of Subordinate Voting Shares by shareholders in the public market may have an adverse effect on the market price.

Future Outlook

Green Thumb Industries expects first-quarter 2026 revenues to be sequentially down mid-single digits. This anticipated decline is attributed to continued pricing pressure within the cannabis market and typical seasonal trends. The company also anticipates 2026 capital expenditures to be approximately $80 million, maintaining a similar level to its 2025 spend.

Management Comments

• "The Green Thumb team delivered record fourth-quarter revenue of $311 million, up 5.7% year-over-year, capping a year in which full-year revenue grew 3.4% to $1.2 billion despite ongoing price compression."
• "We ended 2025 with cash of $274 million and considerable financial flexibility through a senior credit facility that does not mature until September 2029. In addition, last weeks $50 million increase to that credit facility brings new cash onto an already strong balance sheet to deploy for the benefit of shareholders."
• "Our 2025 performance reflects our teams focus on driving operational efficiencies, strengthening our balance sheet, and expanding our retail footprint and brand reach."
• "RYTHM was the No. 1 flower brand across the country, and our team should be incredibly proud. In fact, RYTHMs Animal Face, a core Icon Strain, was the No. 1 selling flower unit in the country in 2025."
• "While cannabis reform in D.C. continues to stall, we have the flexibility to act and be aggressive in what we believe is a major new consumer category."
• "Our strong balance sheet and consistent cash generation provide the foundation for disciplined capital allocation and long-term value creation."
• "In 2025, we invested in high-return growth opportunities, expanding our retail footprint by 12 stores to 113 locations across 14 states."
• "Our strategy of investing ahead of adult-use legalization continues to deliver results, most notably in Minnesota, where our eight RISE Dispensaries transitioned to adult-use in September and contributed meaningfully to fourth quarter performance."
• "Since September 2023, we have repurchased the equivalent of approximately 15.5 million Subordinate Voting Shares for $121.8 million, reflecting our confidence in our business, our team, and our intense focus on optimizing shareholder value."
• "This structure enables RYTHM, Inc. to operate as a non-plant-touching, federally compliant business while allowing us to continue manufacturing cannabis products under licensing agreements, positioning both businesses to capitalize on evolving regulatory frameworks and growing consumer demand for THC products."

Industry Context

StockSavvy.ai notes that Green Thumb's performance in 2025, particularly the revenue growth despite "ongoing price compression," highlights the challenging yet expanding nature of the U.S. cannabis market. The successful transition to adult-use in Minnesota underscores the importance of strategic market entry ahead of legalization, a common growth driver for multi-state operators. The company's brand leadership in key categories (RYTHM, Dogwalkers, incredibles) suggests strong consumer loyalty and product quality differentiation, which is crucial in a competitive and fragmented industry. The stalled cannabis reform in D.C. continues to be a sector-wide headwind, forcing companies like Green Thumb to focus on state-level opportunities and operational efficiencies. The strategic separation of hemp and cannabis IP reflects an industry trend towards optimizing business structures for potential federal compliance and future market evolution.

Comparison to Industry Standards

• Green Thumb's full-year 2025 revenue growth of 3.4% to $1.2 billion, while positive, indicates a slowdown compared to the rapid expansion seen in earlier years of the U.S. cannabis industry, reflecting broader market maturation and increased competition.
• The decline in gross profit margin from 52.9% in 2024 to 48.9% in 2025, primarily due to price compression, is a trend observed across many U.S. cannabis operators as markets mature and supply increases, putting pressure on profitability.
• The negative comparable sales growth of -1.8% in Q4 2025 for established stores suggests that even leading operators are facing headwinds in existing markets, requiring new store openings and adult-use transitions (like Minnesota) to drive overall revenue growth.
• The company's strong cash flow from operations ($294.9 million for the full year) and significant cash balance ($274.3 million) position it favorably compared to many smaller, capital-constrained cannabis companies that often struggle with liquidity due to limited access to traditional banking and capital markets.
• Green Thumb's share repurchase program, totaling $121.8 million since September 2023, demonstrates a commitment to shareholder returns, a practice more common among mature industries and less frequent in the still-developing cannabis sector, indicating financial strength and management confidence.
• The expansion of 12 new retail locations in 2025, bringing the total to 113, aligns with the growth strategies of other large multi-state operators (MSOs) like Curaleaf and Trulieve, which continue to expand their physical footprints to capture market share in newly legalized or expanding adult-use states.

Related Party Transactions

• Fair value adjustments on related party warrants of $125.9 million were primarily associated with the repayment of a $10 million related party convertible note.
• Excluding these adjustments, total other income (expense) would have been unfavorable due to fair value adjustments on the company's equity investments.

Stakeholder Impact

• Shareholders: Benefited from significant share repurchases ($121.8 million since Sept 2023) and increased financial flexibility from the credit facility. However, declining gross margins and negative comparable sales could impact future profitability and share price.
• Employees: The increase in selling, general and administrative expenses was partly attributable to increased compensation costs, suggesting positive impact on employees.
• Customers: Benefit from expanded retail footprint (12 new stores) and continued focus on high-quality, category-leading products (RYTHM, Dogwalkers, incredibles).
• Creditors: The increase in the syndicated credit facility by $50 million and strong cash position ($274.3 million) indicate a healthy ability to manage debt obligations.
• Suppliers: Continued operational expansion and product manufacturing imply ongoing demand for supplier services and goods.

Next Steps

• The company will continue to focus on driving operational efficiencies, strengthening its balance sheet, and expanding its retail footprint and brand reach.
• Green Thumb plans to deploy capital for the benefit of shareholders, including through its ongoing share repurchase program.
• The company will continue to invest in high-return growth opportunities, including expanding its retail footprint.
• Green Thumb will continue to operate under licensing agreements for cannabis product manufacturing, while RYTHM, Inc. operates as a non-plant-touching, federally compliant business.
• The company anticipates 2026 capital expenditures to be approximately $80 million.
• The Annual Report on Form 10-K for the year ended December 31, 2025, including audited financial statements, will be available on the SEC's website and SEDAR+ profile.

Key Dates

Recommendation

While Green Thumb demonstrates strong revenue growth, robust cash flow, and strategic brand leadership in a challenging market, the declining gross margins, negative comparable store sales, and a cautious outlook for Q1 2026 suggest headwinds. The company's proactive share repurchases and balance sheet strength are positive, but the overall picture presents a mixed performance with both growth and profitability pressures. A "hold" recommendation reflects the company's solid foundation and strategic positioning for long-term growth, balanced against current operational challenges and market uncertainties, particularly ongoing price compression and stalled federal reform.

Keywords

Cannabis, Marijuana, Green Thumb Industries, GTII, GTBIF, Financial Results, Earnings, Revenue, EBITDA, Net Income, Dispensaries, Retail Cannabis, Consumer Packaged Goods, Share Repurchase, Adult-Use Cannabis, Minnesota Cannabis, RYTHM, Dogwalkers, incredibles, SEC Filing, Form 8-K